ROME Therapeutics

Verified

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals

About ROME Therapeutics

ROME Therapeutics builds in the biotech category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.

What they do: ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals

Funding context: Andreessen Horowitz, $50M Series B in 2021, $70M valuation

Recent milestones:

ROME Therapeutics appears in the 100Xfounder startup directory import feed.

Why it Matters

ROME Therapeutics matters because rOME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals

Funding Snapshot

Total Funding: $50.00MLast Round: Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuationAll Rounds: 1

Series B | Andreessen Horowitz, $50M Series B in 2021, $70M valuation

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

ROME Therapeutics Team

Founder & CEO

Tech Stack

AWSReactPythonPostgreSQL

Last updated: April 17, 2026

ROME Therapeutics intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Biotech with comparable market signals.

NewLimit

NewLimit Team

View Company Compare Alternatives

Hoxton Farms

Hoxton Farms Team

View Company Compare Alternatives

Kernel

Kernel Team

View Company Compare Alternatives

Synchron

Synchron Team

View Company Compare Alternatives

Clear Labs

Clear Labs Team

View Company Compare Alternatives

BioAge Labs

BioAge Labs Team

View Company Compare Alternatives

Karius

Karius Team

View Company Compare Alternatives

CAMP4 Therapeutics

CAMP4 Therapeutics Team

View Company Compare Alternatives

Discover Now

Newsroom and topic pages connected to ROME Therapeutics.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Company news hub→Founder profile→United States startup directory→United States startup news→Startups in United States→Biotech hub→Biotech startup list→Series B startups→Series B startup list→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About ROME Therapeutics

Common questions people ask about this profile.

What is ROME Therapeutics?

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals

Who founded ROME Therapeutics?

ROME Therapeutics is associated with ROME Therapeutics Team on 100Xfounder.

Where is ROME Therapeutics located?

ROME Therapeutics is listed in Boston, Massachusetts, USA.

What stage is ROME Therapeutics in?

ROME Therapeutics is currently mapped to Series B. Funding context: Andreessen Horowitz, $50M Series B in 2021, $70M valuation

What is the latest funding round of ROME Therapeutics?

ROME Therapeutics's latest tracked round is Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuation. Total tracked rounds: 1.

Is ROME Therapeutics hiring now?

ROME Therapeutics hiring status: Open Roles.

What technologies does ROME Therapeutics use?

ROME Therapeutics is associated with AWS, React, Python, and PostgreSQL.

Is ROME Therapeutics verified on 100Xfounder?

Yes. ROME Therapeutics is currently marked verified on 100Xfounder as of April 17, 2026.

How can users connect with ROME Therapeutics founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.